2026 IP Transactions Bootcamp
February 12, 2026
Location
Seattle, WA
Registration
Join Us February 12, 2026
AIPLA's IP Transactions Committee is hosting an IP Transactions Bootcamp immediately following the AUTM Annual Meeting in Seattle, WA. The AUTM Annual Meeting is a comprehensive program for University Technology Managers. For more information, visit their Conference website.
What to Expect
This in-person-only bootcamp is designed to provide practical insights and strategies for professionals working in intellectual property transactions. The day features a comprehensive agenda including:
- Panels and CLE Sessions: Learn about Working with Tech Transfer Offices, Strategies for successful collaborations between nonprofits and industry, and Protecting and monetizing an AI asset.
- Drafting and Negotiating Tips: Get practical advice on drafting and negotiating strategic collaboration and license agreements.
- Hands-on Workshop: Participate in a Mock licensing negotiation to put your skills to the test.
- Networking: Conclude the day with a dedicated Networking reception.
The cost to attend is $145 per person for AIPLA and AUTM members, which includes breakfast/coffee breaks and the networking reception (lunch is not provided). Non-member (either AIPLA or AUTM) - $595
Current Agenda - Pacific Time
| 8:30 - 9:00 AM | Registration and Coffee |
| 9:00 - 9:15 AM | Opening Remarks |
| 9:15 - 10:00 AM | Panel: Best Practices for Working in and with Non-Profits/Tech Transfer Offices |
| 10:00 - 10:45 AM | Strategies for Successful Collaborations Between Non-profit Research Institutions and Industry (CLE) |
| 10:45 - 11:00 AM | BREAK |
| 11:00 - 12 Noon | Drafting and Negotiating Strategic Collaboration and License Agreements (CLE) |
| 12:00 - 1:15 PM | Lunch on your own (Not included) |
| 1:15 - 2:45 PM | Workshop: Mock Licensing Negotiation |
| 2:45 - 3:00 PM | BREAK |
| 3:00 - 4:00 PM | Managing Dispute Risk in IP Transactions (CLE) |
| 4:00 - 5:30 PM | Networking Reception |
Thank you to our sponsors!

If you would like to sponsor this event, please email Lisa Beller for more information.
Registration
The cost to attend is $145 per person for AIPLA and AUTM members, which includes breakfast/coffee breaks and the networking reception (lunch is not provided). Non-member (either AIPLA or AUTM) - $595
AIPLA Student Members: $25
AUTM members must use this form to register to receive AIPLA member pricing.
Venue Details
Sheraton Grand Seattle Hotel
1400 Sixth Avenue
Seattle, WA 98101
https://www.marriott.com/en-us/hotels/seasi-sheraton-grand-seattle/overview/?scid=f2ae0541-1279-4f24-b197-a979c79310b0
Speakers
-
Weiner, Conna A.
JAMS | Mediator and Arbitrator
Conna A. Weiner, Esq., FCIArb brings to her U.S. and international mediation and arbitration practice a unique combination of litigation, transactional and in-house experience after roles with internationally known outside counsel and multinational life sciences (pharmaceuticals, medical device, diagnostics, vaccines and other therapeutics) and health care companies. She has extensive experience mediating and arbitrating (in-person and virtually) complex general commercial cases in the U.S. and internationally, as well as franchise and employment matters, and serves as a sole arbitrator, neutral party-appointed arbitrator on three member panels and as the chair of arbitration tribunals with many of the major ADR providers. -
Ergmann, Jessica
Broad Institute of MIT and Harvard's Office of Strategic Alliances | Associate Director
Jess Ergmann is an IP and transactional attorney currently serving as the Associate Director of OSAP Legal at Broad where she focuses on negotiating strategic collaboration and license agreements, developing innovative IP strategies, and managing legal operations. With 15 years of experience, Jess is deeply passionate about supporting the development and commercialization of life-saving medical technologies, a focus reflected in her history of developing business-focused IP strategies for both early-stage and large, global life sciences companies. She is also actively involved with AIPLA, where she serves as the Vice Chair of the IP Transactions Committee. -
Herman, Michele
JusTech Law, PLLC | Founder
Michele’s practice at JusTech Law focuses exclusively on legal and business issues affecting technology development and commercialization such as technology standards, open source software, and intellectual property transactions. -
Gosse, David
Nokia | Senior Licensing Attorney
David Gosse manages and resolves complex patent disputes for Nokia, leveraging his expertise in patent law and litigation. He negotiates agreements including pre-litigation resolutions and litigation settlements, regularly representing Nokia in mediation proceedings. -
Lee, Dustin
University of Maryland, Baltimore Office of Technology Transfer | Senior Patent Attorney
Dustin Lee is a Senior Patent Attorney specializing in medical devices, software, and emerging technologies. Additionally, Dustin manages UMB’s Medical Device Prototype Lab. He was an engineer and patent attorney in private practice before joining the Office of Technology Transfer. -
Narasimhan, Dev
Patent Attorney
Dev Narasimhan is a registered patent attorney (70,051) with Bachelors and Masters degrees in Biomedical Engineering, specializing in Biomaterials and Cell and Tissue Engineering. Dev also has extensive experience as an in-house attorney, where he worked with inventors and stakeholders to obtain global patent protection and counseled on patent matters. -
Jackson, Jeff
University of California, Santa Cruz | Director of Innovation Transfer
Jeff Jackson has been the Director of Innovation Transfer at the University of California, Santa Cruz for the past eight years and leads the university’s efforts in invention intake, IP protection, IP policy drafting, review, and compliance, licensing, and (most relevant for this topic) collaborative research agreements. Jeff has over 18 years of experience in academic tech transfer including roles at Oregon Health & Science University and the Translational Genomics Research Institute. -
Casey, Bill
Johnson & Johnson | Senior Patent Counsel
Bill Casey is Senior Patent Counsel, Transactions and leads the Research & Academic Partnerships team for the Innovative Medicines business at Johnson & Johnson. In these roles, Bill supports a range of strategic transactions, including licenses, research collaborations, and mergers and acquisitions, as well as a range of R&D discovery and preclinical agreements with universities, non-profits and government research institutions, to secure rights to innovative medicines in support of Johnson & Johnson’s efforts to develop life-changing and life-saving healthcare solutions for patients. -
Smith, DeAnn
Foley Hoag | Partner
DeAnn Smith provides worldwide strategic patent counseling to biotechnology and pharmaceutical companies and academic and research institutions. She advises on matters relating to intellectual property portfolio strategy, including development, management and enforcement of intellectual assets. -
Reilly, Jay
Foley Hoag | Partner
Jay Reilly is a seasoned transactional and corporate advisor with deep experience serving clients across the life sciences and high-tech industries. He represents biotechnology, pharmaceutical, medical device, diagnostic, and digital health companies—as well as universities and nonprofits—in complex strategic transactions, licensing and collaboration agreements, venture financing and mergers and acquisitions. His work spans both domestic and international markets. -
Robertson, Ragan
MIT TLO | Senior Licensing and Business Development Officer
Ragan Robertson is a Senior Licensing and Business Development Officer at MIT TLO. Ragan has over 15 years of dedicated experience to the dynamic fields of university technology transfer and startup ecosystems. His extensive background encompasses a diverse range of critical business functions, including intricate license negotiations, strategic project management, proactive business development, impactful marketing, patent prosecution, policy development, efficient operations oversight, compliance adherence, effective team management, budgeting, and strategic planning. -
Rishi, Ashwat
Baker Botts | Special Counsel
Ashwat Rishi is a special counsel in the Intellectual Property section of the New York office of Baker Botts. His practice encompasses global patent portfolio strategy, IP counselling, patent litigation, and IP transactions and licensing. His diverse technical experience spans medical devices, mechanical and electro-mechanical products, digital health, data management, data communication and integration, optics, and artificial intelligence.
News
-
AIPLA Comments on CNIPA Draft Measures for Prioritized Patent Examination
April 1, 2026
Arlington, VA. March 30, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the China National Intellectual Property Administration (CNIPA) regarding the Draft Measures for the Administration of Prioritized Examination of Patents. -
AIPLA Files Amicus Brief in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc
March 31, 2026
Arlington, VA. March 27, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus curiae brief with the Supreme Court in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889. AIPLA urges the Court to affirm the Federal Circuit’s application of the established Iqbal/Twombly pleading standard and inducement law in reviewing Hikma’s motion to dismiss Amarin’s claim that Hikma’s conduct, in combination with its “skinny label,” induced infringement of Amarin’s patented treatment methods. -
Supreme Court Issues Unanimous Decision in Cox Communications, Inc. v. Sony Music Entertainment
March 25, 2026
On March 25, 2026, the Supreme Court issued a unanimous decision in Cox Communications, Inc. v. Sony Music Entertainment. The majority opinion limits contributory liability to situations where a party intended that its service be used for infringement, either by affirmatively inducing infringement or by selling a service tailored to infringement. A concurring opinion by Justice Sotomayor argues that the material contribution test should be retained, and that other forms of secondary liability can be found, which is consistent with the position asserted by AIPLA in its amicus brief filed on September 5, 2025. To read the opinion of the Court, please click here. -
AIPLA Comments on the Draft Trademark Law of the People’s Republic of China
March 23, 2026
Arlington, VA. February 9, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the Legislative Affairs Commission of the Standing Committee of the National People’s Congress regarding the latest Draft Trademark Law of the People’s Republic of China. AIPLA recognized the NPC’s efforts to streamline trademark procedures, strengthen protection, and address abusive and bad-faith filing practices. -
AIPLA Files Amicus Brief in USAA v. PNC Bank
March 3, 2026
Arlington, VA. March 2, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief with the Supreme Court in USAA v. PNC Bank, N.A., No. 25-853, in support of USAA’s petition for certiorari, urging the Court to provide much-needed guidance to address the unpredictable and overly broad application of the judicial exceptions to patent-eligible subject matter under 35 U.S.C. § 101, particularly the “abstract idea” exception.
